Work

Response to PD-1 Blockers Alone or Combined with Anlotinib in Treatment of Anaplastic and Poorly Differentiated Thyroid Carcinoma : A Real-world Study to Identify Best-benefited Patients

Year: 2022

Type: preprint

Study design: Observational Study

Source: Research Square

DOI: 10.21203/rs.3.rs-1530139/v1

Authors: Yifei Ma, Youlong Wang, Pengfei Zhu, Jiling Zeng, Ying-Ying Hu, Hao Wu, Huazheng Shi, Wei Fan, Xinjia Wang

Institutions: Shantou University Medical College, Second Affiliated Hospital of Shantou University Medical College, Chinese PLA General Hospital, Sun Yat-sen University Cancer Center, First Affiliated Hospital of Zhengzhou University

Language: English

Topic: Thyroid Cancer Diagnosis and Treatment

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4223975145

Cites: 40

Cited by:

Related to: 10